Table 2.
Parameters | Octreotide group | Placebo group | P** |
---|---|---|---|
GU, n (%) | 21 (36.2) | 20 (34.5) | |
1A | 2 (9.52) | 0 | 0.27 |
1B | 0 | 2 (7.40) | |
2A | 8 (38.09) | 4 (14.8) | |
2B | 0 | 0 | |
2C | 4 (19.04) | 3 (11.11) | |
3 | 7 (33.33) | 11 (40.74) | |
DU, n (%) | 26 (44.8) | 27 (46.6) | |
1A | 1 (3.84) | 1 (3.70) | 0.5 |
1B | 0 | 0 | |
2A | 9 (34.61) | 6 (30) | |
2B | 0 | 0 | |
2C | 8 (33.76) | 6 (22.22) | |
3 | 8 (33.76) | 14 (51.85) |
**Spearman statistical test. DU=Duodenal ulcer, GU=Gastric ulcer